Recombinant alpha‐2B interferon treatment for childhood t‐lymphoblastic disease in relapse. A pediatric oncology group phase II study

Stephen J. Lauer, Judith Ochs, Bradley H Pollock, George R. Buchanan

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Recombinant alpha‐2B interferon treatment for childhood t‐lymphoblastic disease in relapse. A pediatric oncology group phase II study'. Together they form a unique fingerprint.

Medicine & Life Sciences